American Heart Association consortium advances development of evidence-based health tech solutions
Aktivolabs, a digital health science company on a mission to prevent chronic diseases globally, announced today it has joined the American Heart Association Center for Health Technology & Innovation (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.
The Innovators’ Network is a health care technology consortium that connects entrepreneurs, providers, researchers, and payers. Innovators’ Network members also have access to the Association’s digital guidelines, recommendations, and best-in-class science as they develop digital healthcare technologies. Members collaborate with the Center in different ways, including the building of models for clinical outcome studies, lowering the significant cost of developing those studies independently, helping connect the science to technology, and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers.
“The Center aims to advance the rapid, efficient, and effective development of healthcare technology,” said Robert A. Harrington, M.D., FAHA, volunteer past president of the American Heart Association (2019-2020), chair of the American Heart Association’s Health Tech Advisory Group for the Center and the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University. “Joining the Innovators’ Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena.”
“Akitvolabs is honored to be a Digital Health Science company within the American Heart Association Center for Health Technology and Innovation,” says Gourab Mukherjee, Co-Founder and CEO of Aktivolabs. “It is a great opportunity for us to network, learn and contribute to the American Heart Association mission which deeply resonates with us; to be a relentless force for a world of longer, healthier lives.”
Founded in 2017 by medical doctors and data scientists, Aktivolabs is on a mission to prevent chronic diseases globally. The HIPAA compliant real-time digital health platform empowers enterprises and governments to build scalable, evidence-based health & well-being solutions. Clients include the world’s largest Insurance companies, health super-apps, large employers, consumer products companies, and enterprise-level corporations. Aktivolabs investors include Mitsui & Co, SEEDS Capital (the investment arm of Enterprise Singapore), and Adaptive Capital Partners. The company is headquartered in Singapore with offices in New York, Cambridge and India. To learn more, please visit the website www.aktivolabs.com.